C4 Therapeutics (CCCC) Other financing activities (2020 - 2026)

C4 Therapeutics' Other financing activities history runs 7 years deep, the most recent figure standing at $56000.0 for Q1 2026.

• In Q1 2026, Other financing activities fell 48.62% year-over-year to $56000.0; the TTM figure through Mar 2026 stood at $221000.0 (down 45.7% YoY), while the FY2025 annual figure was $274000.0, down 28.27% from the prior year.
• Other financing activities was $56000.0 for Q1 2026 at C4 Therapeutics, up from $1000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $297000.0 in Q3 2024 to a low of -$1000.0 in Q4 2023.
• Historically, Other financing activities has averaged $111538.5 across 5 years, with a median of $104000.0 in 2023.
• The sharpest annual moves came in 2022 and 2023: Other financing activities soared 7433.33% in 2022, then sank 52.73% in 2023.
• A 5-year view of Other financing activities shows it stood at $150000.0 in 2022, then sank by 100.67% to -$1000.0 in 2023, then soared by 200.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025, then jumped by 5500.0% to $56000.0 in 2026.
• The last three Other financing activities figures came in at $56000.0 (Q1 2026), $1000.0 (Q4 2025), and $164000.0 (Q3 2025), per Business Quant data.